Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Return on Equity (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Return on Equity data on record, last reported at 6.33% in Q4 2025.

  • For Q4 2025, Return on Equity fell 631.0% year-over-year to 6.33%; the TTM value through Dec 2025 reached 6.33%, down 631.0%, while the annual FY2025 figure was 0.97%, 93.0% down from the prior year.
  • Return on Equity reached 6.33% in Q4 2025 per INDV's latest filing, down from 0.79% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.16% in Q2 2024 and bottomed at 6.33% in Q4 2025.